Overview

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

Status:
Active, not recruiting

Trial end date:
2021-11-04

Target enrollment:

Participant gender:

Summary

This early phase I clinical trial studies the side effects of topical fluorouracil and imiquimod ointment in treating patients with high-grade cervical intraepithelial neoplasia. Topical fluorouracil may kill precancerous cells. Imiquimod ointment may stimulate the immune system. Applying topical fluorouracil and imiquimod ointment may cause fewer side effects and may be a better way to treat patients with precancerous cervical lesions.

Phase:

Early Phase 1

Details

Lead Sponsor:

National Cancer Institute (NCI)

Treatments:

Fluorouracil
Imiquimod